4 October, 2021 by The TZ Newswire Staff Comments Off on Here’s Why I Think Lemonade Has 10X Potential
Here’s Why I Think Lemonade Has 10X Potential
Insurance technology company Lemonade (NYSE: LMND) is still a relatively small insurance company, and its most exciting market opportunities may still be ahead of it. In this Fool Live video clip, recorded on Sept. 20, Fool.com contributors Matt Frankel, CFP, and Jason Hall discuss why they think Lemonade could be a 10-bagger for patient investors.
4 October, 2021 by The TZ Newswire Staff Comments Off on Investing in Pharma Stocks? Watch for These 2 Red Flags
Investing in Pharma Stocks? Watch for These 2 Red Flags
Pharmaceutical companies can be a great pickup for the conservative portion of your portfolio. Everyone is going to need the life-saving medications that pharmas develop at one point or another, and that means they’re never going to go out of style.
Still, it takes more than making medicines for a drug stock to be lucrative for shareholders, and non-experts might not know what to avoid. Follow along as I explain two of the biggest red flags to be aware of when you’re investing in pharma stocks.
Image source: Getty Images
4 October, 2021 by The TZ Newswire Staff Comments Off on This Unstoppable Growth ETF Could Make You a Multimillionaire
This Unstoppable Growth ETF Could Make You a Multimillionaire
There are plenty of ways to generate wealth, but investing in the stock market is one of the easiest. You don’t need to be rich to make a lot of money investing, and you also don’t need to be experienced in the stock market. All you need is the right investment.
While there are countless stocks and funds to choose from, some investments are better than others. Growth ETFs can be a smart option for many people, and if you invest consistently enough, they could even help you reach multimillionaire status.
4 October, 2021 by The TZ Newswire Staff Comments Off on Could This Smaller Cannabis Stock Overtake Aurora Cannabis in Revenue?
Could This Smaller Cannabis Stock Overtake Aurora Cannabis in Revenue?
Aurora Cannabis (NASDAQ: ACB) is one of the top marijuana stocks in Canada. It has fallen behind both Tilray (NASDAQ: TLRY) and Canopy Growth (NASDAQ: CGC) in terms of revenue, but it’s still a relatively big player in the pot market up north. However, with the company reporting yet another lackluster period this week with respect to revenue growth, it could fall further behind, especially as marijuana producer Hexo (NASDAQ: HEXO) has been trying to grow via acquisitions.
4 October, 2021 by The TZ Newswire Staff Comments Off on SolMonkey becomes the first Solana-based NFT to sell for over $2M
SolMonkey becomes the first Solana-based NFT to sell for over $2M
Solana Monkey #1355 has set a new record for the most expensive non-fungible token (NFT) sold on the Solana network. A report disclosed this news on October 1, noting SMB is part of the Solana Monkey Business (SMB) collection, which comprises 5,000 NFTs minted on Solana. Reportedly, Solana Monkey #1355 sold for 13,027 SOL ($2,000,000).
4 October, 2021 by The TZ Newswire Staff Comments Off on Is the 22% Plunge in Bed Bath & Beyond a Buying Opportunity?
Is the 22% Plunge in Bed Bath & Beyond a Buying Opportunity?
Shares of Bed Bath & Beyond (NASDAQ: BBBY) lost a quarter of their value after the home goods retailer reported fiscal second-quarter results that fell well short of expectations.
While sales were impacted by a rise in COVID-19 cases that led to consumers avoiding stores, the company is in the midst of an existential turnaround and can’t afford to have its recovery delayed.
4 October, 2021 by The TZ Newswire Staff Comments Off on After a Hot Early-2021 IPO, Is Qualtrics Stock a Buy Right Now?
After a Hot Early-2021 IPO, Is Qualtrics Stock a Buy Right Now?
After a hot start early in the year, shares of Qualtrics (NASDAQ: XM) are currently sitting on a 4% decline since making their publicly traded debut in January 2021, compared to a 14% gain for the S&P 500 over that same span of time. Such underperformance isn’t out of the ordinary for IPO stocks, but it is hiding a noteworthy growth story at Qualtrics. The digital experience management software firm is riding a wave of activity as organizations scramble to get their operations upgraded for the cloud era. Is now the time to buy?